Today: 29 January 2026
Subscribe
Browse Category

Pharma Industry News 4 November 2025 - 30 November 2025

Merck Stock (MRK) Outlook Before the December 1, 2025 Market Open: Rally, Ratings and Pipeline Catalysts

Merck Stock (MRK) Outlook Before the December 1, 2025 Market Open: Rally, Ratings and Pipeline Catalysts

Merck & Co., Inc. (NYSE: MRK) heads into the Monday, December 1, 2025 market open riding one of the strongest monthly rallies in the S&P 500, powered by upbeat earnings, dividend growth and a string of bullish analyst calls focused on its post‑Keytruda pipeline. Barron’s Below is a detailed look at how MRK is positioned before the bell, based on…
30 November 2025
····
AbbVie Stock (ABBV) Today: Skyrizi’s Canada Win, Dividend Hike and Big-Money Moves — November 28, 2025

AbbVie Stock (ABBV) Today: Skyrizi’s Canada Win, Dividend Hike and Big-Money Moves — November 28, 2025

AbbVie Inc. (NYSE: ABBV) ended Friday’s session almost unchanged, closing around $227.70 per share, up a negligible 0.02%, after earlier trading slightly in the red. StockAnalysis Even with today’s flat finish, the pharma giant remains one of 2025’s standout healthcare names, with year‑to‑date gains of roughly 30–33%, easily beating the S&P 500. Investing The calm price action masks a busy…
28 November 2025
····
Novo Nordisk Stock Today, 28 November 2025: Goldman Sachs Trims Target as Obesity Pipeline Fights Back

Novo Nordisk Stock Today, 28 November 2025: Goldman Sachs Trims Target as Obesity Pipeline Fights Back

Novo Nordisk (NYSE: NVO) shares are trying to stabilise after a bruising November as fresh obesity‑drug data, a higher‑dose Wegovy filing and new analyst calls collide with lingering worries about growth and competition. 1. How Novo Nordisk stock is trading today Novo Nordisk’s U.S.-listed ADRs are changing hands around $49.25, up roughly 1% on the day, after trading between $48.35 and $49.75 in Friday’s session. Intraday volume…
28 November 2025
···
Eli Lilly (LLY) Stock Outlook Before Market Open on November 28, 2025: Trillion‑Dollar Pharma in Focus

Eli Lilly (LLY) Stock Outlook Before Market Open on November 28, 2025: Trillion‑Dollar Pharma in Focus

As U.S. markets prepare for a shortened Black Friday session on Friday, November 28, 2025, Eli Lilly and Company (NYSE: LLY) will open trading as one of the most closely watched stocks on Wall Street. The drugmaker has just joined the exclusive $1 trillion market‑cap club thanks to explosive demand for its GLP‑1 weight‑loss and diabetes drugs, alongside new momentum…
27 November 2025
···
Eli Lilly (LLY) Stock on November 26, 2025: Trillion‑Dollar Milestone, Pricing Shake‑Up and Stock‑Split Buzz

Eli Lilly (LLY) Stock on November 26, 2025: Trillion‑Dollar Milestone, Pricing Shake‑Up and Stock‑Split Buzz

Eli Lilly and Company (NYSE: LLY) is having another headline‑heavy session on Wednesday, November 26, 2025, as investors digest its new status as the first trillion‑dollar healthcare company, fresh moves on obesity‑drug pricing, and growing chatter about a potential stock split. Reuters As of mid‑afternoon trading, Eli Lilly stock is changing hands around $1,105 per share, down roughly 0.4% on…
26 November 2025
····
Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

As investors head into the Tuesday, November 25 session, Pfizer Inc. (NYSE: PFE) remains one of Wall Street’s most closely watched healthcare names. After a brutal comedown from its pandemic-era highs, the drugmaker is trying to convince the market that a new growth story is taking shape around obesity drugs, oncology and a large – and growing – dividend. As…
25 November 2025
····
Moderna (MRNA) Stock Today, November 23, 2025: Short-Seller Pressure, $1.5 Billion Loan and mRNA Pipeline Reset

Moderna (MRNA) Stock Today, November 23, 2025: Short-Seller Pressure, $1.5 Billion Loan and mRNA Pipeline Reset

Moderna Inc. (NASDAQ: MRNA) enters Sunday, November 23, 2025, as one of the most controversial and heavily shorted stocks in the S&P 500. The biotech is trading near its 52‑week low after the COVID‑vaccine boom faded, yet it’s rolling out a new three‑year strategy, taking on $1.5 billion in debt, cutting pipeline projects and doubling down on its mRNA platform…
23 November 2025
····
Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Pfizer has closed its up to $10 billion acquisition of Metsera (MTSR) and raised $6 billion in bonds to help fund the deal. Here’s what today’s developments mean for former Metsera shareholders, Pfizer investors and the future of the obesity drug market. What Happened Today: Pfizer Locks In $6 Billion Bond Financing The main fresh headline for 21 November 2025…
21 November 2025
····
LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (NASDAQ: LFMD) announced the lowest nationwide cash-pay pricing for Wegovy and Ozempic at $199 per month for new patients, just hours before its rescheduled Q3 2025 earnings release. Here’s what it means for patients, investors, and the GLP‑1 weight-loss market LifeMD Announces $199 Cash-Pay Pricing for Wegovy and Ozempic This morning, LifeMD, Inc. (NASDAQ: LFMD) unveiled what it calls…
17 November 2025
····
Pfizer Stock Surges on Trump Deal & Obesity Drug Drama – Is a Comeback Coming?

Pfizer (PFE) Stock Today — Nov 7, 2025: Metsera Bidding War Intensifies, Dividend Record Date, and What’s Moving the Share Price

Last updated: Nov 7, 2025 (19:23 UTC) Pfizer (NYSE: PFE) shares were trading around $24.28, down roughly 2.3% intraday, as investors weighed new twists in the Metsera takeover fight and marked today’s dividend record date. As of the latest print, the stock’s day range was $24.12–$24.61 on heavy volume. Key takeaways Pfizer stock price today (intraday) What changed today —…
7 November 2025
····
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Stock Today (Nov 6, 2025): NVO steadies as White House GLP‑1 pricing deal lands; $10B Metsera bidding war heats up

Date: Thursday, November 6, 2025Ticker: NVO (NYSE) At a glance: price action and catalysts Novo Nordisk stock traded around $47.36 as of 17:52 UTC, after opening at $47.75 and moving between $46.91–$49.49 on heavy volume. The tape is being driven by two big headlines: (1) a White House pricing agreement that expands access to GLP‑1 drugs across Medicare/Medicaid and a…
6 November 2025
··
Metsera (MTSR) Stock Soars 20% Amid $10B Bidding War – Pfizer vs Novo Nordisk Face Off

Metsera (MTSR) Stock Soars 20% Amid $10B Bidding War – Pfizer vs Novo Nordisk Face Off

Metsera Stock Overview and Recent Performance Metsera’s stock has been on a meteoric rise in recent weeks, capped by a 20% jump on November 4, 2025 alone Reuters Reuters. The share price is now hovering in the low $70s Reuters, a remarkable increase from just around $30–$33 in mid-September before any takeover talks emerged Prnewswire. In fact, over the past…
4 November 2025
····
1 … 4 5 6 7 8

Stock Market Today

  • Corn Futures Rise Amid Weaker Dollar and Wheat Gains
    January 29, 2026, 1:01 AM EST. Corn futures advanced Wednesday, rising 3 to 4 ¼ cents amid strength from wheat markets and a weaker U.S. Dollar index. The national average Cash Corn price increased 4 ½ cents to $3.944. Data from the Energy Information Administration showed ethanol production dropped 5,000 barrels per day last week to 1.114 million bpd, while stocks declined by 339,000 barrels to 25.4 million barrels. Ethanol exports decreased 61,000 bpd, but refiner inputs rose by 31,000 bpd. President Trump expressed support for year-round E-15 ethanol availability. Traders await Thursday's Export Sales figures, anticipating 2025/26 corn bookings between 1 to 2.5 million metric tons.
Go toTop